PIA
USNA icon

Piedmont Investment Advisors’s Usana Health Sciences USNA Stock Holding History

Piedmont Investment Advisors’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-220
Closed -$25K – 2222
2018
Q2 		$25K Buy
+220
New +$24.1K ﹤0.01% 1521

Other funds holding USNA

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Piedmont Investment Advisors's USNA Position: Q3 2018 in Review

Piedmont Investment Advisors sold out of Usana Health Sciences (USNA) in Q3 2018, closing a stake of 220 shares — an estimated $25K sold.

Piedmont Investment Advisors first reported a position in USNA in Q2 2018 and held it in 1 quarter. The position peaked at $25K in Q2 2018. 197 funds tracked by Wall St. Rank hold USNA as of Q3 2018.

  • Piedmont Investment Advisors reported no remaining Usana Health Sciences position as of Q3 2018 after selling out during the quarter.
  • Piedmont Investment Advisors sold 220 Usana Health Sciences shares in Q3 2018, an estimated $25K.
  • Piedmont Investment Advisors first reported a position in Usana Health Sciences in Q2 2018 and held it in 1 quarter.
  • Piedmont Investment Advisors's Usana Health Sciences position peaked at $25K in Q2 2018.
  • 197 funds tracked by Wall St. Rank held Usana Health Sciences as of Q3 2018.

Based on Piedmont Investment Advisors's 13F filing for Q3 2018, filed 8 Nov 2018.